Semaglutide — 10mg

Semaglutide is a long-acting GLP-1 receptor agonist analogue that has become one of the most extensively studied peptides in metabolic and endocrine research. Structurally derived from human GLP-1 with approximately 94% sequence homology, it is modified to resist degradation by DPP-4 enzymes — resulting in a significantly extended half-life compared to native GLP-1.

Mechanism of Interest
Semaglutide binds selectively to the GLP-1 receptor, a pathway central to research into glucose-dependent insulin secretion, glucagon suppression, gastric motility, and appetite-regulating neurological signalling. Its extended half-life makes it particularly well-suited to longitudinal in-vivo metabolic models.

Research Focus Areas
• GLP-1 receptor binding and signalling studies
• Glucose homeostasis and insulin secretion models
• Appetite and satiety pathway research
• Adipose tissue metabolism
• Cardiovascular and inflammation biomarker studies
• Pancreatic beta-cell function modelling

Specifications
• Total content: 10mg
• Form: Lyophilised powder
• Purity: ≥99% — HPLC verified
• Storage: 2–8°C, away from light and moisture

———

Important Notice

This product is supplied strictly for laboratory research use only. It is not intended for human or veterinary use.

By purchasing, the buyer confirms they are a qualified professional or acting on behalf of a licensed research facility and accept full responsibility for safe handling, storage, and use in accordance with all applicable guidelines. No claims are made regarding the safety or effectiveness of this compound outside of a controlled research environment.